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Abstract
Background: A method to evaluate and analyze the massive data generated by series of
microarray experiments is of utmost importance to reveal the hidden patterns of gene expression.
Because of the complexity and the high dimensionality of microarray gene expression profiles, the
dimensional reduction of raw expression data and the feature selections necessary for, for example,
classification of disease samples remains a challenge. To solve the problem we propose a two-level
analysis. First self-organizing map (SOM) is used. SOM is a vector quantization method that
simplifies and reduces the dimensionality of original measurements and visualizes individual tumor
sample in a SOM component plane. Next, hierarchical clustering and K-means clustering is used to
identify patterns of gene expression useful for classification of samples.
Results: We tested the two-level analysis on public data from diffuse large B-cell lymphomas. The
analysis easily distinguished major gene expression patterns without the need for supervision: a
germinal center-related, a proliferation, an inflammatory and a plasma cell differentiation-related
gene expression pattern. The first three patterns matched the patterns described in the original
publication using supervised clustering analysis, whereas the fourth one was novel.
Conclusions: Our study shows that by using SOM as an intermediate step to analyze genome-
wide gene expression data, the gene expression patterns can more easily be revealed. The
"expression display" by the SOM component plane summarises the complicated data in a way that
allows the clinician to evaluate the classification options rather than giving a fixed diagnosis.
Background
The development and progression of cancer is accompa-
nied by complex changes in the patterns of gene expres-
sion. That can be revealed by DNA microarrays analysis
[1]. However, to reliably identify expression patterns asso-
ciated with tumor type, prognosis or therapy, hundreds of
samples need to be studied, and powerful data mining
tools are needed. Microarray experiments are generally
performed without a priori hypothesis. Therefore, the
data mining tools have to be developed that reveal a max-
imum of information to generate new hypotheses [9] with
minimal supervision. Hierarchical clustering is a frequent-
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[5,6]. Notably, the most important genes defining the
branches of the clustering tree are not readily recognized,
and important patterns can be lost due to the determinis-
tic nature of clustering or the high dimensionality of data.
To solve this problem, we propose a two-level analysis
[14] for the study of complex gene expression data. This
analysis summarizes the data by the SOM component
plane, and then clusters the SOM to investigate the feature
gene expression patterns. The SOM reduces the dimen-
Figure 1
Classification of samples by SOM analysis and K-means clustering. SOM component planes are shown for a) 42
DLBCL samples and three DLBCL cell lines (OCILy3, OCILy10 and OCILy1). SOM map size is (22 × 14) and the color scale of
SOM component plane represented the mean ratio in each map node, and red indicates high expression, blue indicates low
expression. See supplementary information for full data. b) K-means clustering of SOM, mean SOM component planes for
DLBCL, FL and CLL. The cluster numbers are given, and the genes contained within each SOM node and K-means cluster are
listed in the web supplement [13], selected genes from clusters 10, 11 and 1, 7, 9 are listed in table 1.Page 2 of 9
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BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/36Table 1: Selected genes grouped to cluster 1,7,9,10,11 of K-means clustering of SOM. Full list can be found in the web supplement [13].
Cluster No. Clone ID Gene Description
Cluster 1 100 Ki67 (long type)
1287099 Survivin = apoptosis inhibitor = effector cell protease EPR-1
108294, 1287528 XRCC9 = DNA repair protein
950690, 824709 Cyclin A
563130, 824060 Cyclin B1
1288839, 325880 Tubulin-beta
1240822, 588637 Actin = cytoskeletal gamma-actin
683084 Cyclin E2
1356512 Similar to MCM2 = DNA replication licensing factor
703757 MPP1 = Putative M phase phosphoprotein 1
1240595 Tubulin-alpha
1341540, 781047 BUB1 = putative mitotic checkpoint protein ser/thr kinase
Cluster 7 789182 PCNA = proliferating cell nuclear antigen
1288183, 235938 BAK = BCL-2 family member
80592 Syndecan-1
469256, 1322301 Bag-1 = Bcl-2 interacting anti-apoptotic protein = RAP46 = Glucocorticoid 
receptor-associated protein
525540 BCL-3
1338456, 364941 C-myc binding protein
784012 40S ribosomal protein S21
324144 Ribosomal protein S29
1087015, 1240788 Ribosomal protein S9
510395 Ribosomal protein S16
272185 Ribosomal protein L27
1335421 Similar to ribosomal protein L37a
1368302 Ribosomal protein L32
Cluster 9 46778 BCL-XL
814478, 1353675 A1 = Bfl-1 = GRs = Bcl-2 related protein
270770, 1272196 IRF-4 = LSIRF = Mum1 = homologue of Pip = Lymphoid-specific interferon 
regulatory factor = Multiple myeloma oncogene 1
1290353 Similar to TREB and X box binding protein 1
145093 MCL1 = myeloid cell differentiation protein
Cluster 10 701606, 1286850, 200814 CD10 = CALLA = Neprilysin = enkepalinase
1337241, 306139 BCL-7A
1340526, 712395 BCL-6
824476, 95093, 1350545 Spi-B transcription factor
1335782, 13194072, 1338245 Oct-2 = lymphoid-specific octamer binding transcription factor = POU
278808 Spi-1 = PU.1 = ets family transcription factor
50214 CD86 = B7-2 = CD28 and CTLA-4 counter-receptor 2
Cluster 11 753794 BLC = BCA-1 = B lymphocyte chemoattractant BLC = CXC chemokine
1326652 CD2
245959 SDF-1 = Stromal cell-derived factor 1 = chemokine
159946 CD14 = monocyte differentiation antigen
1130062 CD3E antigen, epsilon polypeptide
258802, 470615 CD64 = high affinity immunogobulin gamma FC receptor I A form precursor 
= FC-gamma
377560 CD3 delta = T cell surface glycoprotein
505569 T cell receptor beta chain
23435, 1306024 CD11C = leukocyte adhesion protein p150,95 alpha subunit = integrin 
alpha-X
1219244, 57, 1071581 RANTES = chemokine
472180 S100 calcium binding protein A4 = Placental calcium binding protein = Cal-
vasculin
701290 C-C chemokine receptor 5 == CC CK5
47509 Major histocompatibility complex, class II, DN alphaPage 3 of 9
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the data and reveal the gene expression patterns. The vis-
ual inspection of the gene expression patterns in each sin-
gle case, and comparison of those patterns between the
different cases allows identifying common patterns in
gene expression that may have been lost by directly apply-
ing hierarchal clustering to the data. In addition, by K-
means clustering of the SOM, genes that have similar ex-
pression patterns, and might therefore be functionally re-
lated, may be identified.
To test the power of this two-level approach, we applied it
to the analysis of a publicly available gene expression data
set of non-Hodgkin's lymphomas, including mostly dif-
fuse large B-cell lymphoma (DLBCL), follicular lympho-
ma (FL) and chronic lymphocytic leukaemia (CLL). K-
means clustering of the SOM readily identifies four dis-
tinct gene expression profiles: germinal center related,
proliferation, inflammatory and plasma cell differentia-
tion related gene expression patterns. All identified gene
expression patterns are correlated with clinical survival
analysis.
Results
The expression data [10] were filtered and preprocessed as
described and subjected to SOM. Davies-Bouldin index
was used to find the optimum number of 12 clusters in K-
means clustering of the SOM [14]. Figure 1b shows the K-
means clustering of SOM with map size (22 × 14), where
the number of map units M = 5 N0.5, N is the number of
genes; after M has been determined, the map size is deter-
mined by setting the ratio between column number and
row number of map units equal to the ratio of two biggest
eigenvalues of the training data, and their product is as
close to M as possible [11]. Each hexagonal node of SOM
is a prototype vector representing local averages of the da-
ta, and the nearby nodes have similar prototype vectors.
The genes included in each cluster can be found in the
supplement [13].
Through the proposed two-level approach, one may di-
rectly observe the gene expression pattern of different
lymphoma subtypes, i.e. DLBCL, CLL and FL (figure 1b).
As can be seen from figure 1a, DLBCL primarily showed
four prominent gene expression patterns; distinguished
by gene cluster 10, 11, 1 and the large group of clusters 7
and 9. More detailed illustrations of distinct gene expres-
sion patterns are shown in the supplement [13], summary
of the genes included in these clusters are listed in Table
1. Cluster 10 contains genes were known to be expressed
in germinal center B cells, such as FAK, WIP, CD10, CD27,
CD38, FMR2, BCL-6 and BCL-7A. Cluster 11 contains
genes specifically expressed by T-cells (a.o. CD3, CD2,
TCR), NK cells (a.o. NK4), macrophages (a.o. CD14,
CD63, CD64, CD115) and lymph node dendritic cells
(a.o. S100). Also included are genes coding for chemok-
ines and chemokine receptors (RANTES, BLC, IP10, SLC,
FPR, STRL33.1 and MIP1), which play a major role in the
chemoattraction of inflammatory cells. Furthermore DLB-
CL variably express genes in the adjacent clusters 1, 7 and
9 (figure 1a). Cluster 1 includes genes associated with pro-
liferation (Ki67, cyclin A, BUB1, Cyclin B1, thymidine ki-
nase) whereas clusters 7 and 9 include genes associated
with cell survival (Bcl-XL, defender against cell death 1,
Bfl-1, BAK, Bag-1, MCL1) and plasma cell differentiation
(XBP-1, STAT3, IRF-4, ribosomal proteins) [10].
We subsequently regrouped the DLBCL based on the ex-
pression of each of the identified gene expression patterns
and studied survival differences between the groups thus
formed. We confirmed the better survival (figure 2a) for
those cases expressing genes related to the germinal center
(gene cluster 10) as reported by Alizadeh et al. We further-
more could show that there is a significant improved sur-
vival (figure 2b) of cases expressing genes related to
inflammation (gene cluster 11). Equally, there is a signif-
icant reduced survival (figure 2c) of cases expressing genes
related to cell proliferation, anti-apoptosis and plasma
cell differentiation (clusters 1,7,9). Interestingly, there is
also a significant difference in survival (figure 2d) ob-
tained when cases are subdivided using a combination of
gene expression patterns 10 and 1,7,9 in spite of the low
number of cases. We were further intrigued by the clusters
of genes in groups 7 and 9 that apparently were related to
plasma cell differentiation and are frequently co-ex-
pressed with the genes in cluster 1 (cell proliferation). Hi-
erarchical clustering of DLBCL using only genes in clusters
7 and 9 (figure 3) revealed an interesting pattern of mutu-
ally exclusive expressed genes, including many of which
are of utmost importance for plasma cell differentiation
(XBP-1, STAT3, IRF-4) as well as genes coding for ribos-
omal proteins, known to be highly expressed in plasma
cells. Of interest are the two mutually exclusive patterns of
plasma cell differentiation in DLBCL, suggesting either
different pathways of plasma cell differentiation or differ-
ent stages of differentiation.
Figures 1b shows the mean SOM component planes of
CLL and FL. Typically for CLL the genes in the whole lower
part of the SOM are highly expressed while for FL the
genes in the lower and middle left part of the SOM (cluster
10) are highly expressed. Therefore, the most prominent
distinction between CLL and FL lies in the expression of
genes that are characteristic of germinal center B cells
(cluster 10), as has also been suggested by Alizadeh et al
[10].
Discussion
When microarray measurements are presented in random
order, the patterns of gene expression are impossible toPage 4 of 9
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are frequently used to sort the measurements in such a
way that many patterns can easily be visualized, such as in
figure 3. However, this method suffers from several short-
comings [14], of which the most important is the loss of
information of potentially important patterns in a high
dimensional gene space. Although the number of meas-
ured genes is large there may only be a few underlying
gene components that account for most of the response
variation; for example, only a few linear combinations of
a subset of genes can account for nearly all of the expres-
sion variation among various tumor types. In such a situ-
ation, dimension reduction is needed to reduce the high
dimensional gene space to a low dimensional gene com-
ponent space; for instance, principal component analysis
[18] and partial least squares [20] had been applied to the
dimension reduction of microarray data. Thus, we pro-
posed a two-level analysis, first to summarize the gene ex-
pression data by a large set of prototypes; then the
prototypes are further combined to form the actual clus-
ters in the next step. SOM is a suitable method for data re-
duction since it creates a set of prototype vectors
representing the gene expression data and carries out a to-
pology preserving the projection of the prototypes from
the high-dimensional gene space into a low-dimensional
map. To preserve the cluster structure of original data in a
low-dimensional map, we can select as many prototype
vectors as needed, where the number of prototypes equals
Figure 2
Clinically distinct DLBCL subgroups defined by gene expression profiling. a) Kaplan-Meier plot of overall survival of
DLBCL patients grouped on the basis of gene expression profiling in K-means cluster 10. b) Kaplan-Meier plot of overall sur-
vival of DLBCL patients grouped on the basis of gene expression profiling in K-means cluster 11. c) Kaplan-Meier plot of over-
all survival of DLBCL patients grouped on the basis of gene expression profiling in K-means cluster (1,7,9). d) Kaplan-Meier
plot of overall survival of DLBCL patients grouped on the basis of gene expression profiling in K-means cluster 10 and cluster
(1,7,9).Page 5 of 9
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Selected genes from K-means clusters. Hierarchical clustering of 72 selected genes from K-means cluster 1, 7 and 9.
Depicted are the measurements of gene expression from DLBCL, FL and CLL samples. The dendrogram is colour coded
according to the category of sample studied (see upper right key). Each row represents a separate cDNA clone on the micro-
array and each column a separate mRNA sample. The squares presented represent the ratio of hybridisation of fluorescent
cDNA probes prepared from each experimental mRNA sample to reference mRNA sample. These ratios are a measure of rel-
ative gene expression, and red indicates high expression, green indicates low expression and grey indicates missing or excluded
data. See supplementary information for full data [13].Page 6 of 9
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the probability density function of the data and is very ro-
bust with regard to missing data points [7]. Furthermore,
the component plane of SOM can be used as a visualiza-
tion surface for showing different features of the SOM
(and thus of the gene expression data), for example the
cluster structure [14]. By clustering the SOM, a good in-
sight into the cluster structure (and thus of the feature
gene expression patterns) can be obtained.
We applied this two-level approach to the analysis of a set
DLBCL samples that have previously been published. The
inspection of the maps obtained through our analysis
clearly reveals four major gene expression patterns. One
pattern concerns genes expressed by germinal center B
cells (cluster 10), the second could be called an 'inflam-
matory' pattern and relates to genes expressed by T-cells
and macrophages (cluster 11). The third pattern is an ex-
tensive collection of genes involved in cell proliferation
(cluster 1), which seems to be closely linked to the fourth
pattern, anti-apoptosis and plasma cell differentiation-re-
lated genes (cluster 7, 9). This last pattern has not previ-
ously been described whereas the others were also
discovered by Alizadeh et. al, by using hierarchical cluster-
ing only.
The survival data based on the grouping of cases according
to the different gene expression patterns show that all
these expression patterns were significantly correlated
with survival (figure 2a, 2b, 2c). When the germinal center
B cell gene expression pattern (cluster 10) is combined
with the proliferation/anti-apoptosis/plasma cell differ-
entiation pattern (cluster 1,7,9), thus yielding four groups
(figure 2d), significant differences in survival are still seen
notwithstanding the low number of cases. It is of particu-
lar interest that all but one of the cases expressing high lev-
els of germinal center (cell) genes but low levels of
proliferation/anti-apoptosis/plasma cell genes, have a sur-
vival beyond 5 years (figure 2d). This contrasts sharply
with the cases expressing low levels of germinal center B
cell genes but high levels of proliferation/anti-apoptosis
and plasma cell differentiation genes of which none sur-
vive beyond 5 years. Although these data need to be con-
firmed in larger series of cases, a division of DLBCL
according to expression of a combination of genes relating
to the germinal center, proliferation, anti-apoptosis and
plasma cell differentiation seems to be very relevant in
predicting prognosis. Why the expressions of genes related
to cell proliferation, anti-apoptosis and plasma cell differ-
entiation are frequently co-expressed in DLBCL is not
known and needs to be further investigated. It is apparent
from our further analysis (figure 3) that there are two mu-
tually exclusive patterns of gene expression related to plas-
ma cell differentiation. One pattern contains the
transcription factors IRF4 and XBP-1, which have both
been shown to be important for plasma cell differentia-
tion, as well as STAT3, which is part of the IL-6 signaling
pathway involved in plasma cell differentiation [15–17].
The other pattern shows many unknown genes in addi-
tion to genes coding for ribosomal proteins. The latter
suggests an expression pattern related to a later stage of
plasma cell differentiation. These patterns are intriguing
but more studies on normal plasma cell differentiation
are needed in order for these plasmas to be fully under-
stood.
In conclusion, we propose a two-level approach for the
analysis of gene expression patterns, where the clustering
analysis is carried out in a set of summarized prototype
vectors created by SOM. By applying the current two-level
approach to the DLBCL data set [10], the discovered gene
expression patterns were consistent with the ones origi-
nally published. In addition, a novel pattern of gene ex-
pression related to plasma cell differentiation was
revealed. Our results underscore the value of the two-level
analysis for discovering gene expression patterns, and the
method should be useful as a part of routine classification
of clinical samples, when the suggested subdivision have
been confirmed in large studies.
Methods
Sources of experimental data
All experimental data including the survival data of the
lymphoma patients were obtained from the web supple-
ment to the publication of Alizadeh et al. [10] [http://
llmpp.nih.gov/lymphoma/data.shtml].
Preprocessing of data
The data were cleaned before doing any data mining. This
includes flagging and removal of bad measurements, i.e.
measurements where the fluorescent intensity in one
channel was less than 1.4 times the local background were
discarded [10], and replacement of values for identical
probes (same IMAGE number and gene) with the mean
ratio. After cleaning the original data, we were left with
values for 3906 genes from 96 samples, and these ratios
were log 2 transformed.
Hierarchical clustering
Hierarchical clustering [12] is an agglomerative clustering
usually having the following steps: 1) Initialization: as-
sign each vector (the series of values from a single sample)
to its own cluster. 2) Computation of the distance be-
tween all clusters. 3) Merging the two clusters that are
closest to each other. Step 2 and 3 are repeated until there
is only one cluster left. In this work, log 2 transformed ra-
tios were median-centered before clustering, Pearson cor-
relation was used as distance matrixes and the centered
average linkage method was used for merging. Hierarchi-Page 7 of 9
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the Cluster and Tree View software from Stanford [2].
Self-organizing map (SOM) and K-means clustering
The basic SOM [7] consists of m neurons located on a reg-
ular low-dimensional grid, usually 1- or 2- dimensional.
The lattice of the grid is hexagonal. The basic SOM algo-
rithm is iterative. Each neuron i has a d-dimensional pro-
totype vector mi= [mi1, ..., mid], d is the input vector
dimension. Before the training phase, initial values are
given to the prototype vectors and typically linear initiali-
zation was used. At each training step, a sample data vec-
tor x is randomly chosen from the training set. Distances
between x and all the prototype vectors are computed.
During training, the SOM behaves like a flexible net that
folds onto the "cloud" formed by the training data. Be-
cause of the neighborhood relations, neighboring proto-
types are pulled to the same direction, and thus prototype
vectors of neighboring units resemble each other [11]. To
inspect the cluster structure of the map, the SOM compo-
nent plane (figure 1) was used to show the gene expres-
sion features of various tumor samples, and also the
common gene expression patterns of each tumor type.
Each component plane can be thought of as a slice of the
map: it consists of the values of a single vector component
in all map units. It is visualized as 2-dimensional color
images, where the color of a map unit corresponds to its
value. By visualizing the spread of values of that compo-
nent and comparing component planes with each other,
correlations are revealed as similar patterns in identical
positions of the component planes. Based on overall view,
it is easy to select interesting component combinations
and map units for further investigation. To be able to
more effectively study interesting groups of map units,
methods to give good candidates for map unit clusters or
groups are required. Thus, the trained prototype vectors
mi of SOM is further clustered by K-means clustering and
combined to form the actual clusters, more detailed de-
scription of clustering of the SOM can be found in the ear-
ly paper [14].
K-means clustering is a partition clustering, it classifies the
data into k groups, which together satisfy the require-
ments of a partition: (1) Each group must contain at least
one object. (2) Each object must belong to only one
group. To select the best k among different partitions,
each of these can be evaluated using some kind of validity
index. In our calculations, we used the Davies-Bouldin in-
dex [11], which minimizes the ratio between within-clus-
ter distance and between-cluster distance, indicating good
clustering results for spherical clusters with low values. Be-
cause no unified theory for determining the number of
clusters has been fully developed and accepted, the selec-
tion of optimal number of clusters remains as an active re-
search field [19,21]. Thus, the Davies-Bouldin index used
here is only a guideline to estimate the best clustering
among the partitionings with different number of clusters.
Some problems need to be noted when clustering the
SOM by the K-means clustering, due to the properties of
the algorithm: it not only searches for spherical clusters
but also clusters with roughly equal number of samples,
the non-spherical cluster could not be properly recog-
nized as one cluster; and as the number of clusters is in-
creased, the number of samples in clusters decreases,
which makes the algorithm more sensitive to outliers.
Therefore, we have to carefully verify the results obtained
by K-means clustering [14].
In this work, SOM and K-means clustering were carried
out by the SOM toolbox in MATLAB [11]. SOM was
trained using batch version of the algorithm for raw ex-
pression data. All prototype vectors were linearly initial-
ized in the subspace spanned by the two eigenvectors with
greatest eigenvalues computed from the training data. The
SOM was trained in two phases: a rough training with
large initial neighborhood width and a fine-tuning phase
with small initial neighborhood width. The neighbor-
hood width decreased linearly to 1; neighborhood func-
tion was Gaussian. The training length of the two phases
was 1 and 4 epochs and the initial neighborhood width 3
and 1, respectively.
Survival analysis
The statistical treatment of survival times is known as sur-
vival analysis. From a set of observed survival times from
a sample of individuals we can estimate the proportion of
the population of such people who would survive a given
length of time in the same circumstances. The method
yields a graph, the Kaplan-Merier survival curve, is drawn
as a "step function" that changes at every distinct survival
time. The time of survival observations are indicated by
ticks on the survival curve, which shows at a glance the
survival times of the surviving subjects (figure 2). To com-
pare the survival experience of two or more groups of sub-
jects we calculate the logrank test. The logrank test is a
hypothesis test for testing the null hypothesis that the
groups being compared are samples from the same popu-
lation as regards survival experience, it involves calculat-
ing the observed and expected numbers of failures in
separate time intervals, and summing these, comparing
the results to a χ2 distribution with k-1 degrees of freedom
gives P value, where there are k groups of observations [9].
The plotting of Kaplan-Merier survival curves and logrank
test of significance level P value were implemented in
MATLAB.
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